Dr. Babirak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
71 Us Route 1 Ste J
Scarborough, ME 04074Phone+1 207-396-6433Fax+1 207-396-6436
Education & Training
University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 1986 - 1989
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1983 - 1986
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1983
Certifications & Licensure
NH State Medical License 1998 - Present
ME State Medical License 1997 - 2025
PA State Medical License 1992 - 1998
TX State Medical License 1991 - 1992
WA State Medical License 1986 - 1991
MN State Medical License 1984 - 1986- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2013
- Diabetes Recognition Program National Committee for Quality Assurance, 2012-2015
- Fellow (FACE) American Association of Clinical Endocrinology
Publications & Presentations
PubMed
- 136 citationsAlirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial.Patrick M. Moriarty, Klaus G. Parhofer, Stephan P. Babirak, Marc-Andre Cornier, P. Barton Duell
European Heart Journal. 2016-12-21 - 2 citationsA retrospective analysis of clinical use of alirocumab in lipoprotein apheresis patients.Anne C. Goldberg, Richard L. Dunbar, Linda C. Hemphill, Stephan P. Babirak, Gerald Wilson
Journal of Clinical Lipidology. 2020-08-18 - 12 citationsAlirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trialPatrick M. Moriarty, Klaus G. Parhofer, Stephan P. Babirak, Emil M. deGoma, P. Barton Duell
Journal of Clinical Lipidology. 2016-05-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
